When was Daye founded?

Daye was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is Daye located?

Daye is headquartered in London, United Kingdom.

Which legal entities is Daye associated with?

Daye is associated with Anne's Day Ltd.

How many employees does Daye have?

As of Jul 31, 2026, the latest employee count at Daye is 116.

Is Daye a funded company?

Daye is a funded company, having raised a total of $19.2M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 07, 2018.

How much is Daye worth?

The latest valuation of Daye is $***** as of May 17, 2019.

When was the latest funding round of Daye?

Daye's latest funding was a $***** Series A round on Nov 21, 2025, with participation from 0 investor.

What is the annual revenue of Daye?

Annual revenue of Daye is between £1M and £10M as on Dec 31, 2023

Where does Daye rank among its competitors?

Daye ranks 1st amongst 33 active competitors, of which 5 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was bioLOCKEY Healthworks, which secured $66.2K in Feb, 2026.

Who are the top competitors of Daye?

Daye's top competitors include Beikang Medical, Intignus Biotech and bioLOCKEY Healthworks. Among them, bioLOCKEY Healthworks secured the most recent funding round in February, 2026.

Daye - 2026 Company Profile, Team, Funding, Competitors & Financials

Daye is a series A company based in London (United Kingdom), founded in 2018 by Valentina Milanova. It operates as a Manufacturer of period care products and provider of health tests. Daye has raised $19.2M in funding from investors like Index Ventures, Khosla Ventures and Kindred Capital, with a current valuation of $*****. The company has 33 active competitors, including 5 funded and 1 that has exited. Its top competitors include companies like Beikang Medical, Intignus Biotech and bioLOCKEY Healthworks.

Company Details

Manufacturer of period care products and provider of health tests. Offerings include organic tampons, hemp pads, and diagnostic screening kits for vaginal health, hormonal balance, and fertility. Consultations with healthcare professionals are available to interpret diagnostic results and provide clinical guidance. The business supplies supplements for gut and vaginal microbiome support. All diagnostic testing is performed by accredited laboratories, and products are manufactured according to medical device standards.

Website: www.yourdaye.com/
Social
Email ID: *****@yourdaye.com

Key Metrics

Founded Year

2018

Location

London, United Kingdom

Stage

Series A

Total Funding

$19.2M in 4 rounds

Latest Funding Round

Series A, Nov 21, 2025, $*****

Post Money Valuation

$***** as on May 17, 2019

Investors

Index Ventures & 25 more

Ranked

1^st among 33 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2023

Employee Count

116 as on Jul 31, 2026

Similar Companies

Beikang Medical & 36 more

View Daye's full profile

Daye is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Anne's Day Ltd CIN: 11044785 , United Kingdom, Active	Nov 01, 2017	£1M - £10M (As on Dec 31, 2023)	8 (As on Dec 31, 2024)

Daye has raised a total funding of $19.2M over 4 rounds. Its first funding round was on Sep 07, 2018. Daye has 16 institutional investors and 10 angel investors.

Here is the list of recent funding rounds of Daye:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 21, 2025	6382423	Series A	4020448	8360372	9570580	5774585
Oct 26, 2022	4771439	Series A	2758523	4301951	2536874	MassMutual Ventures & 5 more
May 10, 2019	4378528	Series A	1920383	6668482	Khosla Ventures	Index Ventures & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Daye's funding rounds and investors

The founders of Daye is Valentina Milanova.

Here are the details of Daye's key team members:

Valentina Milanova: Founder & CEO of Daye. They serve on the board of 1 company.
Contact Info: 1 email address

Daye's Board of Directors

Daye's board has 2 active members. Valentina Milanova is part of team and Kristina Simmons is independent board member.

Here is the list of Daye's board of directors:

Name	Type	Representing	Status	Duration
Valentina Milanova	Team	-	Current	8y 9m
Kristina Simmons	Independent board member	-	Current	7y 3m
onshwhc	Independent board member	-	Past	1y 2m
efmunlx	Independent board member	-	Past	3y 8m

View details of Daye's Founder profiles and Board Members

Daye's employee count trend

Daye has 116 employees as of Jul 26. Here is Daye's employee count trend over the years:

Uncover Daye's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Daye include Beikang Medical, Intignus Biotech and bioLOCKEY Healthworks. Here is the list of Top 10 competitors of Daye, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	MassMutual Ventures, Hummingbird Ventures ... & 24 others	56/100
2nd	Beikang Medical 2010, Suzhou (China), Public	Developer of NGS-based diagnostic solutions for neonatal	$36.5M	Broad Vision Funds, Yixiang Capital & 3 others	43/100
3rd	Intignus Biotech 2018, Pune (India), Seed	Manufacturer of early diagnosis device for pregnancy-related disorders	$289K	Indian Institute of Technology Kanpur, Venture Center ... & 7 others	39/100
4th	bioLOCKEY Healthworks 2023, Bengaluru (India), Seed	Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform	$478K	Pfizer, Pfizerindovation & 7 others	37/100
5th	Heranova Lifesciences 2022, Burlington (United States), Seed	Developing diagnostics and treatments for womens health	$13.5M	Pivotal bioVenture Partners China	36/100
6th	Latde Diagnostics 2021, Amherst (United States), Funding Raised	Developer of diagnostic test for urinary tract infections	-	University Lab Partners, HHS	30/100
7th	Sabera Healthcare 2021, Mangaluru (India), Unfunded	Developer of point-of-care diagnostic devices focused on women's health	-	-	28/100
8th	Droplet Health 2017, San Francisco (United States), Funding Raised	Provides home based kit for diagnosis of women health	-	MaC Venture Capital, Designer Fund & 2 others	27/100
9th	Koroglu Medical 2008, Izmir (Turkey), Unfunded	In vitro diagnostic assays and devices	-	-	27/100
10th	SDCMed 2018, London (United Kingdom), Funding Raised	Provider of DNA based technology for diagnostic solution of infectious diseases	-	MassChallenge	25/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Daye's competitors? Click here to see the top ones

Founders (largest shareholder) own 51.40%, Funds own 47.30%, Enterprises own 0.30% and Angels own 0.70%. The net worth of Daye's founders is INR 6.34M as of May 17, 2019.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	51.40%	6.34M	5786577	9833744	7156415	1805132
Valentina Milanova	7256547	1035243	7188217	2984376	3377871	9584332
Fund	47.30%	5.84M	8383705	3719650	8078035	8710381
Khosla Ventures	1149254	4010095	3217253	4995890	2785405	6455618
Index Ventures	6642546	6054149	8114944	5371527	8233909	3645442
Kindred Capital	7994051	7436122	4569887	5946369	6917426	4941489
Enterprise	0.30%	31.8K	0	0	0	0
Angel	0.70%	73.9K	0	0	0	0
Total	99.70%	1.23Cr	5773960	2840854	4886712	7461335